These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7389321)

  • 1. A FORTRAN program for the optimization of radiotherapy treatment planning using the complication probability factor (CPF).
    Wolbarst AB; Sternick ES; Curran BH; Kosinski RJ; Dritschilo A
    Comput Programs Biomed; 1980 Apr; 11(2):99-104. PubMed ID: 7389321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complication probability factor: a method for selection of radiation treatment plans.
    Dritschilo A; Chaffey JT; Bloomer WD; Marck A
    Br J Radiol; 1978 May; 51(605):370-4. PubMed ID: 638408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Optimization criteria in intensity-modulated radiotherapy].
    Sauer OA
    Z Med Phys; 2003; 13(2):99-107. PubMed ID: 12868335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized radiotherapy treatment planning using the complication probability factor (CPF).
    Wolbarst AB; Sternick ES; Curran BH; Dritschilo A
    Int J Radiat Oncol Biol Phys; 1980 Jun; 6(6):723-8. PubMed ID: 7451276
    [No Abstract]   [Full Text] [Related]  

  • 5. Response-probability volume histograms and iso-probability of response charts in treatment plan evaluation.
    Mavroidis P; Ferreira BC; Lopes Mdo C
    Med Phys; 2011 May; 38(5):2382-97. PubMed ID: 21776773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ideal dose level in treatment planning optimization.
    Begnozzi L; Malaspina F; Gentile FP; Chiatti L; Carpino S; Fragomeni R; Benassi M
    Strahlenther Onkol; 1992 Oct; 168(10):588-92. PubMed ID: 1440230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple method to calculate the influence of dose inhomogeneity and fractionation in normal tissue complication probability evaluation.
    Begnozzi L; Gentile FP; Di Nallo AM; Chiatti L; Zicari C; Consorti R; Benassi M
    Strahlenther Onkol; 1994 Oct; 170(10):590-4. PubMed ID: 7974170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy.
    Tsougos I; Mavroidis P; Rajala J; Theodorou K; Järvenpää R; Pitkänen MA; Holli K; Ojala AT; Lind BK; Hyödynmaa S; Kappas C
    Phys Med Biol; 2005 Aug; 50(15):3535-54. PubMed ID: 16030381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal tissue complication probability modelling of tissue fibrosis following breast radiotherapy.
    Alexander MA; Brooks WA; Blake SW
    Phys Med Biol; 2007 Apr; 52(7):1831-43. PubMed ID: 17374914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiobiology for beginners].
    Coucke P; Martinive P
    Rev Med Liege; 2014; 69 Suppl 1():16-9. PubMed ID: 24822300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of dose volume histogram reduction algorithms for normal tissue complication probability calculations.
    Cozzi L; Buffa FM; Fogliata A
    Acta Oncol; 2000; 39(2):165-71. PubMed ID: 10859006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of radiation therapy: integral-response of a model biological system.
    Wolbarst AB; Chin LM; Svensson GK
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1761-9. PubMed ID: 7153088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of radiation-induced normal tissue complications in radiotherapy using functional image data.
    Nioutsikou E; Partridge M; Bedford JL; Webb S
    Phys Med Biol; 2005 Mar; 50(6):1035-46. PubMed ID: 15798307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of the dose level for a given treatment plan to maximize the complication-free tumor cure.
    Lind BK; Mavroidis P; Hyödynmaa S; Kappas C
    Acta Oncol; 1999; 38(6):787-98. PubMed ID: 10522770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell population kinetics in radiation therapy: optimization of tumor dosage.
    Cohen L
    Cancer; 1973 Jul; 32(1):236-44. PubMed ID: 4716777
    [No Abstract]   [Full Text] [Related]  

  • 16. Statistical methods for clinical verification of dose-response parameters related to esophageal stricture and AVM obliteration from radiotherapy.
    Mavroidis P; Lind BK; Theodorou K; Laurell G; Fernberg JO; Lefkopoulos D; Kappas C; Brahme A
    Phys Med Biol; 2004 Aug; 49(16):3797-816. PubMed ID: 15446806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region.
    Roesink JM; Moerland MA; Battermann JJ; Hordijk GJ; Terhaard CH
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):938-46. PubMed ID: 11704314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of the DMF model taking into account volume and area of irradiated tissue to the prognosis of radiation complications].
    Pavlov AS; Kostromina KN; Fadeeva MA; Datsenko VS; Klepper LIa
    Med Radiol (Mosk); 1986 Nov; 31(11):3-8. PubMed ID: 3784822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A set of fortran subroutines for optimizing radiotherapy plans.
    Redpath AT; Vickery BL; Wright DH
    Comput Programs Biomed; 1975 Dec; 5(2):158-64. PubMed ID: 1201655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.